Page 941 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 941

672     PART 5: Infectious Disorders


                 Findings can vary from normal to hyperintense lesions.  Treatment is   neurologic abnormalities, gastrointestinal symptoms, and seizures. The
                                                          60
                 supportive care; several vaccines are in the developmental stages. 61  diagnosis can be made by testing serum and CSF for IgM and neutral-
                     ■  JAPANESE ENCEPHALITIS VIRUS                    izing antibodies. A fourfold increase in convalescent phase IgG antibody
                                                                       titer is required to establish the diagnosis. Treatment is supportive. Case-
                 Japanese encephalitis virus (JEV) is an arbovirus of flaviviridae family,   fatality rate is 10% to 15% with a high incidence of residual neurologic
                 spread to humans by mosquito bites (culex), and is a major public health   abnormalities among survivors.
                 problem in Southeast Asia, causing around 50,000 cases and 10,000 deaths      ■  MURRAY VALLEY ENCEPHALITIS VIRUS
                 per year especially in children below 10 years of age.  JEV causes severe
                                                       62
                 fatal  encephalitis  with  high  mortality  and  survivors  are  left  with     Murray Valley encephalitis virus is found in Australia and New Guinea,
                 severe neurologic sequelae. JEV infection is most often asymptomatic.   transmitted to humans by mosquitoes and mostly affects the aboriginal
                 When  symptoms  are  present,  they  usually  manifest  as  meningitis,    children. Illness may progress rapidly in children with a case fatality rate
                 seizures, and motor paralyses. A progressive decline in alertness may   of 15% to 30%. Diagnosis is made by the detection of IgM antibody in
                 take place, eventually progressing to coma.  Recovery usually leaves   the CSF or demonstrating a fourfold increase in IgG antibodies in paired
                                                  63
                 serious neurologic sequelae such as persistent altered sensorium, extra-  acute and convalescent sera. MRI may show high signal intensities in
                 pyramidal syndrome, epileptic seizures, and severe mental retardation.   basal ganglia. Treatment is supportive.
                 asymmetric hemorrhagic lesions of the thalamus are characteristically   ■  TICK-BORNE ENCEPHALITIS VIRUS
                 The JE virus shows a fairly strong tropism for the thalamus, and bilateral
                 seen on MRI and CT.  Hyponatremia from inappropriate antidiuretic   Tick-borne encephalitis virus (TBE) is found in Eastern Russia, central
                                 64
                 hormone secretion is reported. JEV specific anti-IgM antibody detec-  Europe, and the Far East. The virus is transmitted to humans by ticks.
                 tion by ELISA may help establish a diagnosis. HSV, dengue virus, and   Outbreaks of TBE viral encephalitis have been reported following
                 West Nile virus are the major viruses to be considered in differential     ingestion of unpasteurized milk products from infected sheep and goat.
                   diagnosis. Treatment is usually supportive and there is no effective anti-  Clinical  spectrum  of  illness  ranges  from  mild  to  severe  encephalitis
                 viral treatment. Prevention is by vector control and vaccination. 62  along with myelitis- and poliomyelitis-like paralysis. 68,69  Diagnosis is
                     ■  ST LOUIS ENCEPHALITIS                          made by the detection of IgM antibody in the serum and CSF or dem-
                                                                       onstrating a fourfold increase in IgG antibodies in paired acute and
                 St Louis encephalitis (SLE) is endemic in western United States, with   convalescent sera. In the early viremic phase, TBE virus may be cultured
                                                                       from blood. Treatment is supportive.
                 large periodic outbreaks in the eastern United States, Central and South
                 America. It is the second leading cause of epidemic viral encephalitis in
                 the United States, after West Nile virus. The illness is mostly seen during   PICORNAVIRIDAE
                 summer months when the vector, culex mosquito is active. Symptomatic   Encephalitis causing viruses in the Picornaviridae family are distributed
                 illness is uncommon in children; among adults, 1 in 300 exposed to the   worldwide and can be grouped into polio and nonpolio enteroviruses.
                 virus develop symptomatic illness.  The incubation period is 4 to 21 days    With a few exceptions, the predominant mode of transmission is by the
                                          65
                 after the bite of an infected mosquito. Illness begins with a prodrome of   ingestion of food or water contaminated with feces. Coxsackievirus A21
                 flu-like symptoms such as fever, headache, myalgia, nausea, and vomit-  is transmitted via respiratory secretions.
                 ing. Clinical features of SLE include altered sensorium, seizures, cranial
                 nerve palsies, eyelid and lip tremors, nystagmus, ataxia, myoclonic move-    ■  POLIOVIRUS
                 ments, and coma. A unique feature in SLE is the development of urinary   Poliovirus is a neurotropic virus, the causative agent of paralytic polio-
                 symptoms  such  as dysuria,  urgency, and incontinence  prior  to the   myelitis. The virus is primarily transmitted by fecal oral route with
                 appearance of central nervous system signs. CSF analysis is consistent   pharyngeal spread occurring during epidemics. Incubation period is 1
                 with viral meningitis with mild elevation in protein, normal to mildly   to 2 weeks and over 90% of infections are asymptomatic. Presentation
                 decreased glucose, and WBC counts ranging from 50 to 500 cells/µL    of symptomatic illness is similar to a viral illness. Initial symptoms are
                 with mononuclear cell predominance. Syndrome of inappropriate   headache, fever, nausea, vomiting, and malaise. In infants this may
                 secretion of antidiuretic hormone (SIADH) has been documented in   progress to meningoencephalitis with altered sensorium and seizures.
                 one-third of patients. A positive serum IgM ELISA provides a presump-  Paralytic polio occurs in less than 1% of all polio infections and may
                 tive diagnosis of SLE, but a fourfold increase in convalescent phase IgG   present as asymmetric flaccid paralysis, diaphragmatic and respira-
                 antibody titer is required to establish the diagnosis. False-positive serol-  tory muscle paralysis leading to respiratory failure. Lower extremities
                 ogy due to cross-reaction with other flaviviruses, especially West Nile   are more often involved than the upper extremities. Poliovirus causes
                 virus, can occur. The presence of SLE-specific IgM antibody in the CSF   damage only to the motor neurons, therefore the sensation is preserved.
                 is indicative of infection of the central nervous system, and by day 7 of   Oral polio vaccine (OPV) has been associated with a few cases of acute
                 illness, 100% of CSF samples will yield a positive result. Abnormalities   flaccid paralysis. Outbreaks of poliomyelitis due to vaccine derived
                 specific to SLE have not been identified in brain imaging. MRI of the   strains  of  virus  have  occurred,  when  OPV  was  administered  in  areas
                 brain may show hyperintense lesions in the basal ganglia, substantia   with low immunization rates. This is unlikely to occur in the USA, as the
                 nigra, and thalamus. Treatment is supportive. There are no approved   Advisory Committee on Immunization Practices has recommended the
                 antiviral agents available for the treatment of SLE, though interferon-  use of inactivated polio vaccine for primary immunization since 2000.
                 α-2b may reduce the severity and duration of complications associated   Early in the illness, CSF evaluation reveals predominance of polymor-
                 with SLE. 47,66  Case-fatality rate is 3% to 30% with higher rates seen in   phonuclear cells with a shift to lymphocytic predominance after a few
                 persons over the age of 60 years.                     days. CSF protein concentration is often elevated to 100 to 300 mg/dL
                     ■  POWASSAN VIRUS                                 and the glucose concentration is normal. Virus can be cultured from
                                                                       pharyngeal secretions and stool. CSF culture for the virus is unreliable.
                 Powassan virus is a rare cause of encephalitis in the New England states   The diagnosis can be confirmed by PCR amplification of poliovirus
                 and eastern Canada. Rodents are the reservoir for the virus, which is   RNA in the CSF. Serologic testing by demonstrating a fourfold increase
                 transmitted by ticks to humans. Infection occurs mostly during summer   in convalescent phase antibody titer can also be used to establish the
                 months and asymptomatic infection is more common than symptomatic   diagnosis. At the present time, treatment of poliomyelitis is supportive.
                 illness.  The  incubation  period  is  about  8  to  34  days.   When  symp-  None of the available antiviral agents have demonstrated any benefits in
                                                         67
                 tomatic, patients often present with fever, headache, confusion, focal   the treating this enterovirus-associated acute paralysis.







            section05_c61-73.indd   672                                                                                1/23/2015   12:48:46 PM
   936   937   938   939   940   941   942   943   944   945   946